Skip to main content

Table 5 Relation of the FIB level and all-cause death in patients with different glycemic metabolism status

From: Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study

Variables Events/subjects HR (95% CI)
214/6140 Crude model Adjusted model
NG
 FIB-L 7/537 Reference Reference
 FIB-M 13/433 2.35 (0.94–5.87) 2.08 (0.83–5.22)
 FIB-H 14/424 2.62 (1.06–6.49) * 1.96 (0.79–4.89)
Pre-DM
 FIB-L 21/1011 1.59 (0.68–3.74) 1.24 (0.53–2.93)
 FIB-M 33/944 2.73 (1.21–6.12) * 2.17 (0.96–4.93)
 FIB-H 40/929 3.40 (1.52–7.58) ** 2.27 (1.01–5.12) *
DM
 FIB-L 15/521 2.23 (0.91–5.46) 1.67 (0.68–4.10)
 FIB-M 29/656 3.45 (1.51–7.89) ** 2.57 (1.12–5.89) *
 FIB-H 42/685 4.91 (2.20–10.92) ** 3.04 (1.35–6.82) **
  1. Model adjusted for age, sex, BMI, hypertension, diabetes, family history of CAD, prior PCI/CABG, LVEF, LDL-C, creatine, DES implantation, clopidogrel, ACEI/ARB
  2. CI confidence interval, FIB fibrinogen, NG normoglycemia, Pre-DM prediabetes, DM diabetes mellitus
  3. * P value < 0.05, ** P value < 0.01